Iopamiro 300

Iopamidol, the active ingredient in Iopamiro 300, is an iodinated contrast media presented as a 300 mg I/mL injectable solution for intraarterial, intraarticular, or intrathecal use. It provides radiodensity that enhances X‑ray visualization of vascular, joint and spinal structures during diagnostic imaging procedures. GNH USA supplies Iopamiro 300 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iopamiro 300, an iodinated contrast agent, is employed in diagnostic imaging procedures that require vascular, joint or spinal contrast enhancement.

Angiography: improves visualization of blood vessels and vascular lesions. Arthrography: enhances delineation of joint spaces and cartilage. Myelography: provides contrast for spinal canal and nerve root imaging. Other diagnostic imaging procedures: supplies intra‑vascular, intra‑articular or intrathecal contrast for a range of radiographic studies.

Iopamiro 300 may cause a range of adverse reactions following injection.

Common Side Effects: - Warmth or flushing sensation at the injection site - Nausea or vomiting - Metallic taste in the mouth - Mild headache - Transient hypotension or dizziness - Injection site pain or bruising

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis - Contrast‑induced nephropathy or acute renal failure - Seizures or convulsions - Cardiac arrhythmias or severe hypotension - Pulmonary edema or respiratory distress - Persistent skin rash or urticaria

Prior to administration, clinicians should evaluate patient-specific risk factors and follow safe handling practices.

Assess renal function: check serum creatinine and eGFR before use. Review allergy history: avoid in patients with known iodine or contrast media hypersensitivity. Use lowest effective iodine dose: tailor volume to imaging requirement. Monitor vital signs: observe for hemodynamic changes during and after injection. Avoid in severe renal impairment: consider alternative imaging modalities. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iopamiro 300 can interact with other agents that affect renal function or iodine load.

Major Interactions (Avoid): - Concurrent administration of other iodinated contrast media: cumulative iodine may increase toxicity. - Use with nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): heightened risk of renal injury. - Co‑administration with metformin in patients with reduced renal function: risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Concomitant diuretics: may alter fluid balance and affect contrast distribution. - Beta‑blockers or antihypertensives: monitor blood pressure for additive hypotensive effects. - Systemic steroids: may mask early signs of allergic reactions.